Literature DB >> 25660647

On-label and off-label drug use in the treatment of female infertility.

Rebecca S Usadi1, Kathryn S Merriam2.   

Abstract

Female infertility affects millions of couples worldwide and is estimated to account for one-third of all cases of infertility. The purpose of this article is to review the uses of both off-label treatments and those approved by the US Food and Drug Administration for female infertility, by examining the mechanism of action, the side-effect profile, fetal anomaly risks, and contraindications for the various drugs.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Female infertility; medications for female infertility

Mesh：

Substances：

Year:  2015        PMID： 25660647     DOI： 10.1016/j.fertnstert.2015.01.011

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  8 in total

1.  Novel compound heterozygous mutations in WEE2 causes female infertility and fertilization failure.

Authors:  Xiaopei Zhou; Lixia Zhu; Meiqi Hou; Yanling Wu; Zhou Li; Jiarui Wang; Zhenxing Liu; Dazhi Zhang; Lei Jin; Xianqin Zhang
Journal:  J Assist Reprod Genet       Date:  2019-08-19       Impact factor: 3.412

Review 2.  Chinese medicine as complementary therapy for female infertility.

Authors:  Ju-Feng Xia; Yoshinori Inagaki; Jian-Feng Zhang; Ling Wang; Pei-Pei Song
Journal:  Chin J Integr Med       Date:  2016-08-02       Impact factor: 1.978

3.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

4.  Medication-Wide Association Study Using Electronic Health Record Data of Prescription Medication Exposure and Multifetal Pregnancies: Retrospective Study.

Authors:  Lena Davidson; Silvia P Canelón; Mary Regina Boland
Journal:  JMIR Med Inform       Date:  2022-06-07

Review 5.  Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Alexandra P Tsiami; Dimitrios G Goulis; Alexandros I Sotiriadis; Efstratios M Kolibianakis
Journal:  Hormones (Athens)       Date:  2021-05-25       Impact factor: 2.885

Review 6.  Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article.

Authors:  Dariush D Farhud; Shaghayegh Zokaei; Mohammad Keykhaei; Marjan Zarif Yeganeh
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

7.  A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserve.

Authors:  Russell Frank; Naama Steiner; Maryam Al Shatti; Jacob Ruiter-Ligeti; Michael H Dahan
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

Review 8.  Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis

Authors:  Rui Wang; Bobae V Kim; Madelon van Wely; Neil P Johnson; Michael F Costello; Hanwang Zhang; Ernest Hung Yu Ng; Richard S Legro; Siladitya Bhattacharya; Robert J Norman; Ben Willem J Mol
Journal:  BMJ       Date:  2017-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.